GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes

Our findings including novel gout risk loci provide further understanding of the molecular pathogenesis of gout and lead to a novel concept for the therapeutic target of gout/hyperuricaemia.